e-learning
resources
Munich 2006
Sunday 03.09.2006
Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD and asthma patients: what can they expect of high altitude residences?
G. Menz (Davos, Switzerland)
Source:
Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Session:
Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Session type:
Symposium
Number:
1663
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Menz (Davos, Switzerland). COPD and asthma patients: what can they expect of high altitude residences?. Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Why is it important to consider (sub)phenotypes of asthma and COPD?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
The influence of the weather on COPD admissions
Source: Annual Congress 2007 - Primary care: managing special cases in lung disease
Year: 2007
Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002
Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Phenotypic markers of asthma and COPD at the tissue level
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005
Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics
Source: International Congress 2015 – Different data in COPD
Year: 2015
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
COPD in farming
Source: Annual Congress 2006 - Farming – a worldwide problem
Year: 2006
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Delivery of asthma and chronic obstructive pulmonary disease (COPD) services in UK primary care: nurses‘ roles and responsibilities
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept